Pharmacokinetics, Safety and Tolerability of EDP-239, a Novel Hepatitis C (HCV) NS5A inhibitor, in Patients with HCV Infection

Press/Media: Press / Media

PeriodOct 1 2015

Media coverage

1

Media coverage

  • TitlePharmacokinetics, Safety and Tolerability of EDP-239, a Novel Hepatitis C (HCV) NS5A inhibitor, in Patients with HCV Infection
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date10/1/15
    PersonsFred Poordad, Eric J Lawitz